Suppr超能文献

肥胖 Zucker 大鼠体内的降钙素、降钙素基因相关肽及肾脏降钙素受体

Calcitonin, calcitonin gene-related peptide and renal calcitonin receptors in the Zucker rat.

作者信息

Seitz P K, Cooper C W

机构信息

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.

出版信息

Bone Miner. 1987 Feb;2(1):53-62.

PMID:2849490
Abstract

In this study we investigated (a) whether genetically obese Zucker rats exhibit higher levels of calcitonin gene-related peptide (CGRP) in the thyroid and plasma than lean controls, (b) if CGRP, like calcitonin (CT), increases in plasma in response to iv Ca or iv pentagastrin and (c) whether or not renal CT receptors exhibit 'downregulation' in fat rats compared to leans. Fat and lean rats 8-12 months old were used. Compared to leans, fat rats exhibited higher circulating levels of CGRP as well as CT. Also, the total thyroid content (micrograms per gland) and concentration (ng/mg wet weight) of CGRP were higher in fat rats. One minute after iv pentagastrin, both lean and fat rats showed a marked increase in plasma CT but not plasma CGRP. In another experiment involving only lean rats, iv Ca given 4 min earlier produced a massive increase in plasma CT but no detectable increase in plasma CGRP. Using renal membranes and 125I-sCT as the ligand, we found that renal CT receptors in fat rats appeared more abundant than in lean rats and exhibited the same KD (3-6 nM) for both. The findings show that, compared to leans, fat rats have higher levels of CGRP as well as CT in the thyroid gland and blood. However, stimulation of C-cell release of CT was not accompanied by a corresponding rise in plasma CGRP, suggesting that either (a) the plasma CGRP is derived largely from non-thyroidal sources and the adult rat thyroid releases only trivial amounts of CGRP or (b) Ca and pentagastrin are secretagogues for thyroidal CT but not CGRP. Examination of renal CT receptors in fat and lean rats provided no evidence for downregulation of receptors in fat rats exposed chronically to higher circulating levels of CT than leans.

摘要

在本研究中,我们调查了:(a) 遗传性肥胖的 Zucker 大鼠甲状腺和血浆中降钙素基因相关肽 (CGRP) 的水平是否高于瘦对照大鼠;(b) CGRP 是否像降钙素 (CT) 一样,静脉注射钙或静脉注射五肽胃泌素后血浆中会升高;(c) 与瘦大鼠相比,肥胖大鼠肾脏中的 CT 受体是否表现出“下调”。使用了 8 - 12 月龄的肥胖和瘦大鼠。与瘦大鼠相比,肥胖大鼠的 CGRP 以及 CT 的循环水平更高。此外,肥胖大鼠甲状腺中 CGRP 的总含量(微克/腺体)和浓度(纳克/毫克湿重)也更高。静脉注射五肽胃泌素 1 分钟后,瘦大鼠和肥胖大鼠的血浆 CT 均显著升高,但血浆 CGRP 未升高。在另一项仅涉及瘦大鼠的实验中,提前 4 分钟静脉注射钙导致血浆 CT 大幅升高,但血浆 CGRP 未检测到升高。使用肾膜和 125I - sCT 作为配体,我们发现肥胖大鼠肾脏中的 CT 受体似乎比瘦大鼠更丰富,并且两者的 KD(3 - 6 纳摩尔)相同。研究结果表明,与瘦大鼠相比,肥胖大鼠甲状腺和血液中 CGRP 以及 CT 的水平更高。然而,刺激 C 细胞释放 CT 并未伴随血浆 CGRP 相应升高,这表明要么 (a) 血浆 CGRP 主要来自非甲状腺来源,成年大鼠甲状腺仅释放微量 CGRP,要么 (b) 钙和五肽胃泌素是甲状腺 CT 的促分泌剂,但不是 CGRP 的促分泌剂。对肥胖和瘦大鼠肾脏 CT 受体的检查未发现长期暴露于比瘦大鼠更高循环水平 CT 的肥胖大鼠受体下调的证据。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验